Episodes

Top Ten Potential Surprises for 2022

Episode #238 | December 23, 2021

Episode #238 | December 23, 2021

Top Ten Potential Surprises for 2022

In This Episode

This week, Dan invites one of the most respected healthcare analysts anywhere in the world onto the show…

His work has been featured in the Wall Street Journal, Bloomberg, the Financial Times, Kiplinger, CBS, and USA Today – just to name a few.

In fact, he was previously ranked by Fortune magazine as the No. 1 health care analyst in the U.S.

And today, he’s here to talk about one of the best value plays anywhere in the stock market.

The one and only Tom Carroll.

Tom knows the healthcare industry landscape as well as anyone. In fact, that’s what led him to start his newsletter with Stansberry Research, Cannabis Capitalist.

According to Tom, nationwide federal legalization of cannabis is inevitable. It’s a matter of when and not if, which gives investors an incredible opportunity right now…

You can get into these stocks at a better value than you could one year ago… but today many of these companies have better revenues, earnings, and balance sheets than ever before…

Tom says if you ignore this opportunity, you’ll likely come to regret it…

Plus, he even shares the name and ticker symbol of THREE of his favorite cannabis stocks that he’s recommended to his readers…

If you’ve considered entering the cannabis space, but weren’t sure the best way to go about it, this is an episode you don’t want to miss…